News

Discover the seven primary causes of thyroid disorders affecting women, from autoimmune triggers and hormonal fluctuations to ...
Knowledge on vitamin D in horses is lacking, not only about how equines obtain the nutrient from different sources and how effective each source is, but also about how much is necessary to sustain ...
The thyroid gland produces the thyroxine hormone that regulates metabolism (energy release and levels), and acts like a ...
- Revumenib abstracts highlight compelling results in acute leukemia across the frontline and R/R setting and multiple genetic populations, including mNPM1, KMT2Ar, and NUP98r - - Axatilimab abstracts ...
The mechanism determining the preferential stimulation of one heterotrimeric G protein signaling pathway over another by a ligand remains undetermined. By reporting the cryogenic electron microscopy ...
Hypoparathyroidism (hypoPT), is one of the rare endocrine disorders that are not routinely managed by hormone replacement as a first-line therapy. In patients with hypoPT, parathyroid hormone (PTH ...
Auxin is the first plant hormone—or "phytohormone"—ever identified, with its discovery dating to the late 19th and early 20th ...
A pioneering research study details how the hormone FGF21 (fibroblast growth factor 21) can reverse the effects of fatty liver disease in mice. The hormone works primarily by signaling the brain to ...
Hyperparathyroidism is characterized by high levels of parathyroid hormone. This hormone plays an important role in regulating levels of calcium and phosphorus in your blood. When calcium levels ...
Hypomagnesemia is associated with hypoparathyroidism (hypoPT) because magnesium is required for efficient synthesis and secretion of parathyroid hormone (PTH). Hypomagnesemia associated with ...
This important study investigated whether the nuclear receptor Nur77 is regulated by a non-canonical mechanism of ligand-induced disruption of its interaction with RXRg, similar to the family member ...
About 95% of people with MEN1 develop parathyroid tumors by age 50. People with MEN1 have a high risk of developing tumors and health problems related to abnormally high hormone levels caused by ...